BEAM ▼ -0.8% - Beam Therapeutics Inc. $BEAM - Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer Beam Therapeutics appointed Eric Foster as Chief Commercial Officer, a leadership move typically aimed at strengthening the company's commercial strategy and market execution. The stock declined 0.8% today, suggesting investors may have had limited enthusiasm for the appointment or were awaiting additional strategic announcements alongside the executive hire. 01-SEP-2026 07:00 AM ET